Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice

Author(s): Yamanaka H, Tohma S

Abstract

For better management of rheumatoid arthritis (RA) patients, we need information both from well-designed clinical trials, such as randomized controlled trials, and from observational cohorts. Observational cohort study has not been developed in Japanese RA patients; however, two cohorts, IORRA (formerly J-ARAMIS) from 2000 and NinJa by iR-net from 2002, have been established. These two cohorts are an important source not only for better management of Japanese RA patients but also for solutions to a variety of issues concerning RA clinical practice in general. In this minireview, necessities of observational cohort studies are discussed.

Similar Articles

Cardiovascular death in rheumatoid arthritis: a population-based study

Author(s): Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE

Mortality of rheumatoid arthritis in Japan: a longitudinal cohort study

Author(s): Hakoda M, Oiwa H, Kasagi F, Masunari N, Yamada M, et al.

Cause of death in 81 autopsied patients with rheumatoid arthritis

Author(s): Suzuki A, Ohosone Y, Obana M, Mita S, Matsuoka Y, et al.

Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility

Author(s): Bakker MF, Jacobs JW, Verstappen SM, Bijlsma JW

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

Author(s): Choi HK, Hernán MA, Seeger JD, Robins JM, Wolfe F

[Cause of death in autopsied RA patients]

Author(s): Toyoshima H, Kusaba T, Yamaguchi M

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Author(s): Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al.

Death certificate and mortality in rheumatoid arthritis

Author(s): Laakso M, Isomäki H, Mutru O, Koota K

Natural history and outcome in systemic AA amyloidosis

Author(s): Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, et al.

The mortality of rheumatoid arthritis

Author(s): Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, et al.